drugset / Trial / NCT06732466
Evaluation of the Effect of a Toothpaste Containing 0.3% Chlorhexidine in Subjects With Established Dental Plaque and Gingivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase III, one-center, parallel group, double blind, clinical study to evaluate the effect of a toothpaste containing 0.3% chlorhexidine in subjects with established dental plaque and gingivitis. It involves 80 participants aged between 18 and 70, randomly assigned to different groups, and spans 21 days.
Timeline
- Start
- 2025-03-24
- Primary completion
- 2025-04-15
- Completion
- 2025-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AmCl | Unknown | 3 % | — |
| Subject | Chlorhexidine | Small molecule | 0.3 % | — |